Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells
Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells |
https://doi.org/10.18632/oncotarget.28679
Steven A. Greenberg
|
1-8 |
Retraction: Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-κB signaling pathway in a rat model
Retraction: Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-κB signaling pathway in a rat model |
https://doi.org/10.18632/oncotarget.28572
Bo Zhang,
Dan Wang,
Tie-Feng Ji,
Lei Shi,
and Jin-Lu Yu
|
9-9 |
Retraction: Transient activation of the PI3K/Akt pathway promotes Newcastle disease virus replication and enhances anti-apoptotic signaling responses
Retraction: Transient activation of the PI3K/Akt pathway promotes Newcastle disease virus replication and enhances anti-apoptotic signaling responses |
https://doi.org/10.18632/oncotarget.28683
Yinfeng Kang,
Runyu Yuan,
Xiaqiong Zhao,
Bin Xiang,
Shimin Gao,
Pei Gao,
Xu Dai,
Minsha Feng,
Yanling Li,
Peng Xie,
Yulian Li,
Xiaoyi Gao,
and Tao Ren
|
10-10 |
Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms
Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms |
https://doi.org/10.18632/oncotarget.28680
Whitney L. Hensing,
Emily L. Podany,
James J. Sears,
Shaili Tapiavala,
and Andrew A. Davis
|
11-27 |
Retraction: Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-κB pathway
Retraction: Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-κB pathway |
https://doi.org/10.18632/oncotarget.28684
Xuanyang Hu,
Zhirong Wang,
Jiawei Shi,
Xiaobin Guo,
Liangliang Wang,
Zichuan Ping,
Yunxia Tao,
Huilin Yang,
Jun Zhou,
Yaozeng Xu,
and Dechun Geng
|
28-28 |
Assessment of cfDNA release dynamics during colorectal cancer surgery
Assessment of cfDNA release dynamics during colorectal cancer surgery |
https://doi.org/10.18632/oncotarget.28681
Mailson Alves Lopes,
Maria Elvira Ribeiro Cordeiro,
Flávio de Alencar Teles Barreto,
Lara de Souza Moreno,
André Araújo de Medeiros Silva,
Mariana Braccialli de Loyola,
Mayra Veloso Ayrimoraes Soares,
Joao Batista de Sousa,
and Fabio Pittella-Silva
|
29-38 |
Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report
Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report |
https://doi.org/10.18632/oncotarget.28682
Jenny L. Wu,
and Wade T. Iams
|
39-42 |
Retraction: MicroRNA-145 down-regulates mucin 5AC to alleviate airway remodeling and targets EGFR to inhibit cytokine expression
Retraction: MicroRNA-145 down-regulates mucin 5AC to alleviate airway remodeling and targets EGFR to inhibit cytokine expression |
https://doi.org/10.18632/oncotarget.28689
Zhe Cheng,
Ling-Ling Dai,
Xi Wang,
Liu-Qun Jia,
Xiao-Gang Jing,
Peng-Fei Li,
Meng Liu,
Huan Wang,
and Lin An
|
43-43 |
A case report of donor cell–derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation
A case report of donor cell–derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation |
https://doi.org/10.18632/oncotarget.28686
Aleksandra Mroczkowska-Bękarciak,
and Tomasz Wróbel
|
44-50 |
SETDB1 amplification in osteosarcomas: Insights from its role in healthy tissues and other cancer types
SETDB1 amplification in osteosarcomas: Insights from its role in healthy tissues and other cancer types |
https://doi.org/10.18632/oncotarget.28688
Elodie Verdier,
Nathalie Gaspar,
Maria Eugenia Marques Da Costa,
and Antonin Marchais
|
51-62 |
Correction: Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression
Correction: Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression |
https://doi.org/10.18632/oncotarget.28692
Haolong Li,
Ning Xie,
Martin E. Gleave,
and Xuesen Dong
|
63-64 |
Correction: Downregulation of c-SRC kinase CSK promotes castration resistant prostate cancer and pinpoints a novel disease subclass
Correction: Downregulation of c-SRC kinase CSK promotes castration resistant prostate cancer and pinpoints a novel disease subclass |
https://doi.org/10.18632/oncotarget.28693
Chih-Cheng Yang,
Ladan Fazli,
Salvatore Loguercio,
Irina Zharkikh,
Pedro Aza-Blanc,
Martin E. Gleave,
and Dieter A. Wolf
|
65-66 |
Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen
Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen |
https://doi.org/10.18632/oncotarget.28687
Doaa A. Gamal,
Aiat Morsy,
and Mervat Omar
|
67-78 |
Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells
Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells |
https://doi.org/10.18632/oncotarget.28690
Jessica J. Miciak,
Lucy Petrova,
Rhythm Sajwan,
Aditya Pandya,
Mikayla Deckard,
Andrew J. Munoz,
and Fred Bunz
|
79-100 |
Retraction: Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma
Retraction: Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.28694
Zhikui Liu,
Changwei Dou,
Bowen Yao,
Meng Xu,
Linglong Ding,
Yufeng Wang,
Yuli Jia,
Qing Li,
Hongyong Zhang,
Kangsheng Tu,
Tao Song,
and Qingguang Liu
|
101-101 |
Retraction: Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma
Retraction: Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.28695
Zhikui Liu,
Changwei Dou,
Bowen Yao,
Meng Xu,
Linglong Ding,
Yufeng Wang,
Yuli Jia,
Qing Li,
Hongyong Zhang,
Kangsheng Tu,
Tao Song,
and Qingguang Liu
|
102-102 |
Leukopenia, weight loss and oral mucositis induced by 5-Fluorouracil in hamsters’ model: A regenerative approach using electrospun poly(Lactic-co-Glycolic Acid) membrane
Leukopenia, weight loss and oral mucositis induced by 5-Fluorouracil in hamsters’ model: A regenerative approach using electrospun poly(Lactic-co-Glycolic Acid) membrane |
https://doi.org/10.18632/oncotarget.28685
Ana Chor,
Hélio dos Santos Dutra,
Marcos Lopes Dias,
Raquel Pires Gonçalves,
Alexandre Malta Rossi,
Christina Maeda Takiya,
and Marcos Farina
|
103-117 |